- A 4-strain influenza vaccine for people 36 months of age and older,
- Helps protect children, adults and seniors against both influenza B strains (B/Victoria and B/Yamagata),
- Newest addition to the Vaxigrip® family of influenza vaccines.
Catalyst
Slingshot members are tracking this event:
New Four-Strain Influenza Vaccine, VaxigripTetra, Regulatory Dossier from Sanofi Pasteur Now Approved in Europe
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| SNY |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 23, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Vaxigriptetra, Influenza B Strains, B/yamagata, B/victoria, A/h1n1, A/h3n2, Influenza Vaccines
